Survival of chronic myeloid leukemia patients in comparison to the general population in the tyrosine kinase inhibitors era: A US population-based study

被引：4
|
作者：
Jamy, Omer [1 ]
Godby, Richard [2 ]
Sarmad, Rehan [1 ]
Costa, Luciano J. [1 ]
机构：
[1] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 07期
关键词：
D O I：
10.1002/ajh.26195
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E265 / E268
页数：4
相关论文
共 50 条
  • [21] Is cure for chronic myeloid leukemia possible in the tyrosine kinase inhibitors era?
    Bansal, Aasthaa
    Radich, Jerald
    CURRENT OPINION IN HEMATOLOGY, 2016, 23 (02) : 115 - 120
  • [22] Extreme thrombocytosis in chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Sora, Federica
    Autore, Francesco
    Chiusolo, Patrizia
    Marietti, Sara
    Bayer, Jolanta
    Laurenti, Luca
    Giammarco, Sabrina
    Ausoni, Giuseppe
    Leone, Giuseppe
    Sica, Simona
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2958 - 2960
  • [23] Temporal trend in survival for chronic myelomonocytic leukemia in the US: a population-based study
    Lesegretain, Arnaud
    Brunner, Andrew
    Benzohra, Aziz
    Fathi, Amir T.
    LEUKEMIA & LYMPHOMA, 2023, 64 (13) : 2156 - 2164
  • [24] Impact of Comorbidities on Survival of Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
    Engelbrecht, Fernanda F.
    Miranda, Eliana C.
    Delamain, Marcia Torresan
    Duarte, Gislaine Borba
    Souza, Carmino Antonio
    De Paula, Erich V.
    Pagnano, Katia B.
    BLOOD, 2019, 134
  • [25] Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013
    Beinortas, Tumas
    Tavoriene, Ilma
    Zvirblis, Tadas
    Gerbutavicius, Rolandas
    Jurgutis, Mindaugas
    Griskevicius, Laimonas
    BMC CANCER, 2016, 16
  • [26] Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study
    Al-Husseini, Muneer J.
    Mohamed, Hadeer H.
    Saad, Anas M.
    Gad, Mohamed M.
    Atia, Mona
    Qaddoora, Umniyah
    Abushouk, Abdelrahman Ibrahim
    El-Shinawi, Mohamed
    CURRENT PROBLEMS IN CANCER, 2019, 43 (03) : 213 - 221
  • [27] INCREASING RELATIVE SURVIVAL IN CHRONIC MYELOID LEUKEMIA (CML): A POPULATION-BASED STUDY IN LITHUANIA
    Zvirblis, T.
    Ivanauskaite, V.
    Tavoriene, I.
    Gerbutavicius, R.
    Juozaityte, E.
    Malciute, L.
    Jurgutis, M.
    Daubariene, J.
    Ramanauskiene, D.
    Rageliene, L.
    Griskevicius, L.
    HAEMATOLOGICA, 2012, 97 : 312 - 313
  • [28] Tyrosine kinase inhibitors-related vascular occlusive events in Taiwanese chronic myeloid leukemia patients: a population-based, propensity score-matched cohort study
    Chen, Mei-Tsen
    Huang, Shih-Tsung
    Chen, Ho-Min
    Ko, Bor-Sheng
    Hsiao, Fei-Yuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 583 - 583
  • [29] Tyrosine kinase inhibitors in chronic myeloid leukemia
    Sawyers, CL
    Druker, B
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (02): : 63 - 69
  • [30] The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors
    Haznedaroglu, Ibrahim C.
    Cetiner, Mustafa
    Ilhan, Osman
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2011, 21 (02): : 1 - 3
12345